MyDrHank review

This one will not help you take less, and it is covered for one sentence in its own GLP-1 FAQ: the price stays the same at every dose, no surprise price increases. That is the question this site's readers arrive with, answered in writing by the company rather than inferred from a price table — titrate up and the bill does not follow you. What it is not is a microdosing program. There is no low-dose product, no microdose tier and no start-low protocol anywhere on the site, so beginning small here means asking for a smaller amount inside a standard plan and paying the standard plan's price for it. The other thing to know before you compare its figures with anything else here is that every rate it advertises is a twelve-month prepay rate: its price display takes the cheapest rung of each term ladder, and the month-to-month rate is shown on no page of the site. Its own pricing footnote then quotes a tirzepatide figure that matches none of its four published tirzepatide tiers, and pairs it with a semaglutide figure taken from the oral tablet rather than the injection it sits beside.

Vs median

$90/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

Price last updated

August 2026

MyDrHank does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

MyDrHank (mydrhank.com, operated by Dr. Hank, LLC — the entity is credited by name in the privacy policy and the terms of use) is a prescription telehealth service, never a supplement seller, running six product lines: weight loss, longevity, peptides and NAD+, sexual health, hair growth, and strength. GLP-1 is its self-described "most popular treatment" but it is one shelf among several rather than the whole business. An online intake is reviewed by a U.S.-licensed provider, and the medication is compounded in what the product pages describe only as "an FDA-registered U.S. pharmacy" — no pharmacy is named anywhere on the site. Prices are published before any intake quiz, which is worth something here; what needs saying immediately is what those published prices are. The site's price display takes the minimum of each product's term ladder, so every "From $X/mo" it shows is the twelve-month prepay rung, and the month-to-month rate — $349 for tirzepatide, $259 for injectable semaglutide, $249 for the oral tablet — is rendered on no page at all. The GLP-1 FAQ promises that "the price stays the same at every dose," which is the genuinely relevant fact for a reader intending to stay small; it is also a promise made about standard-dose plans, because MyDrHank publishes no microdose product of any kind.

No microdose or low-dose GLP-1 product of any kind — the word does not appear anywhere on the site or in its application bundle, so starting low here means self-directing a smaller amount inside a standard-dose plan at the standard plan's price

• Every price the site advertises is the twelve-month prepay rung: the display takes the minimum of each term ladder, so the month-to-month rate ($349 tirzepatide, $259 injectable semaglutide, $249 oral) appears on no page of the site
• Its own pricing footnote quotes a tirzepatide figure that exists at no tier — "$200/mo for compounded tirzepatide" matches none of the four published tirzepatide rungs — and the $171 quoted beside it for semaglutide is the ORAL product's yearly rate, not the injectable's, which is $178
• The GLP-1 FAQ calls a twelve-month prepay rate a plan with "no contract"
• The dose-price promise is made on the GLP-1 line only — the NAD+ and Sermorelin landers say the opposite, that "final pricing depends on the protocol and dose prescribed"
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
• No dispensing pharmacy is named — the product pages say only "compounded in an FDA-registered U.S. pharmacy"
• No served-states list is published on any consumer page; the affiliate terms exclude Kansas, Louisiana, Mississippi, New Mexico, North Dakota and West Virginia, so eligibility has to be confirmed before starting

MyDrHank is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Titrating up from a microdose
• Microdose & reconstitution calculator
• Titration planner